Status: Recruiting
Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2
Post-market clinical follow-up (PMCF) investigation to evaluate the performance and safety of AnGelHA 2 filler for the correction of moderate to severe wrinkles and folds and facial contour remodeling, in a routine clinical setting.
Participants needed: 87
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: GlyanceUpdated: May 28, 2026Locations: 1
Eligibility criteria
Men or women of any race, 18 years of age or older. [+1]
Pregnant or lactating women (contraindications as per IFU). [+8]